S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Chaganti
    Chaganti
  6. Lin
    Lin
  7. Tang
    Tang
  8. Clarkson
    Clarkson
  9. Janjigian
    Janjigian
  10. Marghoob
    Marghoob

Groups

  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)
  7. Sloan Kettering Institute Postdocs (55)
  8. Surgery (54)
  9. Sloan Kettering Institute Faculty (47)
  10. Thoracic Oncology (45)
Search Within
Formats
  1. Meeting Abstract (332)
  2. Journal Article (254)
  3. Book Section (20)
  4. Review (15)
  5. Conference Paper (10)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)

More Groups

People
  1. Lisa Bodei (32)
  2. Alexander Drilon (23)
  3. Robert Motzer (23)
  4. Ghassan Abou-Alfa (18)
  5. Steven Hajdu (18)
  6. Oscar Lin (16)

More People

Years
  1. 2025 (3)
  2. 2024 (21)
  3. 2023 (37)
  4. 2022 (42)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Oncology Research and Treatment (226)
  2. Cytogenetics and Cell Genetics (61)
  3. Acta Cytologica (58)
  4. Neuroendocrinology (51)
  5. Acta Haematologica (32)
  6. Onkologie (19)

More Publications

Results (633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematological response
    Meeting Abstract

    Gertz, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Merlini, G.; Schonland, S.; Walling, J.; Kinney, G. G.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Three-year efficacy and safety update from the phase III Checkmate 025 study of nivolumab (NIVO) v everolimus (EVE) in patients with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Sharma, P.; Tykodi, S. S.; Escudier, B.; Carducci, M.; Oudard, S.; Hammers, H. J.; George, S.; Gauna, D. C.; Alva, A. S.; Richardet, M. E.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • TRITON2: An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Heidenreich, A.; Carl, S.; Feyerabend, S.; Gleissner, J.; Grullich, C.; Heinrich, B.; Merseburger, A.; Miller, K.; Stenzl, A.; Steuber, T.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Predicting response to PRRT: Development and validation of a blood-based predictive biomarker
    Meeting Abstract

    Bodei, L.; Kidd, M.; Van der Zwan, W.; Singh, A.; Severi, S.; Drozdov, I.; Cwikla, J.; Baum, R. P.; Paganelli, G.; Kwekkeboom, D.; more...
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Assessment of the clinical utility of the NETest in a US registry-based study
    Meeting Abstract

    Liu, E.; Paulson, S.; Gulati, A.; Freudman, J.; Grosh, W.; Kafer, S.; Wickremesinghe, P.; Salem, R.; Bodei, L.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • A hybrid clinical molecular nomogram accurately predicts survival in PRRT treated GEP-NETs
    Meeting Abstract

    Kidd, M.; Bodei, L.; Severi, S.; Drozdov, I.; Nicolini, S.; Paganelli, G.; Modlin, I. M.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Survival analysis after i.a. 90Y-DOTATATE PRRT, in patients with non-resectable, advanced, progressive, liver-dominant neuroendocrine neoplasms
    Meeting Abstract

    Nowicki, M. L.; Kolasińska-Ćwikła, A.; Lewczuk, A.; Sankowski, A.; Bodei, L.; Buscombe, J. R.; Kidd, M.; Modlin, I.; Ćwikła, J.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in combination with peptide receptor radionuclide therapy (PRRT) in progressive digestive and lung neuroendocrine tumours (NETs): Design of the PRELUDE study
    Meeting Abstract

    Prasad, V.; Thanh, X. M. T.; Houchard, A.; Bodei, L.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Measurement in blood of a circulating NET mRNA gene to predict surgical efficacy
    Meeting Abstract

    Modlin, I. M.; Frilling, A.; Salem, R.; Cichocki, A.; Ćwikła, J.; Bodei, L.; Drozdov, I.; Kidd, M.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Circulating neuroendocrine transcripts and gene cluster analysis predict the efficacy of PRRT
    Meeting Abstract

    Bodei, L.; Kidd, M.; Singh, A.; Severi, S.; Drozdov, I.; Nicolini, S.; Baum, R.; Paganelli, G.; Kwekkeboom, D.; Krenning, E.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save